Scalable Software. Scalable Science.
MOE Citations

2009

Abdel-Megeed, A.M.; Abdel-Rahman, H.M.; Alkaraman, G.-E.S. & El-Gendy, M.A.
Design, Synthesis and Molecular Modeling Study of Acylated 1,2,4-Triazole-3-Acetates with Potential Anti-Inflammatory Activity
European Journal of Medicinal Chemistry 44 (2009) 117–123 doi
Adebiyi, A.P.; Adebiyi, A.O.; Yamashita, J.; Ogawa, T. & Muramoto, K.
Purification and Characterization of Antioxidative Peptides Derived from Rice Bran Protein Hydrolysate
European Food Research and Technology 228 (2009) 553–563 doi
Al-Obaid, A.M.; Abdel-Hamide, S.G.; El-Kashef, H.A.; Abdel-Aziz, A.A.M.; El-Azab, A.S.; Al-Khamees, H.A. & El-Subbagh, H.I.
Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs
European Journal of Medicinal Chemistry 44 (2009) 2379–2391 doi
Appiah-Opong, R.; Commandeur, J.N.M.; Istyastono, E.; Bogaards, J.J. & Vermeulen, N.P.E.
Inhibition of Human Glutathione S-Transferases by Curcumin and Analogues
Xenobiotica 39 (2009) 302–311 doi
Arrault, A.; Rocchi, S.; Picard, F.; Maurois, P.; Pirotte, B. & Vamecq, J.
A Short Series of Antidiabetic Sulfonylureas Exhibit Multiple Ligand PPARγ-binding Patterns
Biomedicine & Pharmacotherapy 63 (2009) 56–62 doi
Ballester, P.J.; Finn, P.W. & Richards, W.G.
Ultrafast Shape Recognition: Evaluating a New Ligand-Based Virtual Screening Technology
Journal of Molecular Graphics and Modelling 27 (2009) 836–845 doi
Barchéchath, S.; Williams, C.I.; Saade, K.; Lauwagie, S. & Jean-Claude, B.
Rational Design of Multitargeted Tyrosine Kinase Inhibitors: A Novel Approach
Chemical Biology & Drug Design 73 (2009) 380–387 doi
Bunch, L.; Gefflaut, T.; Alaux, S.; Sagot, E.; Nielsen, B. & Pickering, D.S.
Pharmacological characterization of (4R)-alkyl glutamate analogues at the ionotropic glutamate receptors—Focus on subtypes iGlu5–7
European Journal of Pharmacology 609 (2009) 1–4 doi
Butler, K.T.; Luque, F.J. & Barril, X.
Toward Accurate Relative Energy Predictions of the Bioactive Conformation of Drugs
Journal of Computational Chemistry 30 (2009) 601–610 doi
Carrascal, N. & Rizzo, R.C.
Calculation of Binding Free Energies for Non-Zinc Chelating Pyrimidine Dicarboxamide Inhibitors with MMP-13
Bioorganic & Medicinal Chemistry Letters 19 (2009) 47–50 doi
Catana, C.
Simple Idea to Generate Fragment and Pharmacophore Descriptors and Their Implications in Chemical Informatics
Journal of Chemical Information and Modeling 49 (2009) 543–548 doi
Cee, V.J.; Cheng, A.C.; Romero, K.; Bellon, S.; Mohr, C.; Whittington, D.A.; Bak, A.; Bready, J.; Caenepeel, S.; Coxon, A.; Deak, H.L.; Fretland, J.; Gu, Y.; Hodous, B.L.; Huang, X.; Kim, J.L.; Lin, J.; Long, A.M.; Nguyen, H.; Olivieri, P.R.; Patel, V.F.; Wang, L.; Zhoud, Y.; Hughes, P. & Geuns-Meyer, S.
Pyridyl-pyrimidine Benzimidazole Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Tie-2 Kinase
Bioorganic & Medicinal Chemistry Letters 19 (2009) 424–427 doi
Chegaev, K.; Cena, C.; Giorgis, M.; Rolando, B.; Tosco, P.; Bertinaria, M.; Fruttero, R.; Carrupt, P.-A. & Gasco, A.
Edaravone Derivatives Containing NO-Donor Functions
Journal of Medicinal Chemistry 52 (2009) 574–578 doi
Chen, Z.; Wen, F.; Sun, N. & Zhao, H.
Directed Evolution of Homing Endonuclease I-SceI with Altered Sequence Specificity
Protein Engineering, Design and Selection 22 (2009) 249–256 doi
Cichero, E.; Casolino, C.; Menozzi, G.; Mosti, L. & Fossa, P.
Exploring the QSAR of Pyrazolo [3,4-b] Pyridine, Pyrazolo [3,4-b] Pyridone and Pyrazolo [3,4-b] Pyrimidine Derivatives as Antagonists for A1 Adenosine Receptor
QSAR & Combinatorial Science 28 (2009) 426–435 doi
Cichero, E.; Cesarini, S.; Fossa, P.; Spallarossa, A. & Mosti, L.
Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: Docking-based CoMFA and CoMSIA analyses
European Journal of Medicinal Chemistry 44 (2009) 2059–2070 doi
Clark, A.M. & Labute, P.
Detection and Assignment of Common Scaffolds in Project Databases of Lead Molecules
Journal of Medicinal Chemistry 52 (2009) 469–483 doi
Colotta, V.; Lenzi, O.; Catarzi, D.; Varano, F.; Filacchioni, G.; Martini, C.; Trincavelli, L.; Ciampi, O.; Pugliese, A.M.; Traini, C.; Pedata, F.; Morizzo, E. & Moro, S.
Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a New Scaffold To Develop Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand–Receptor Modeling Studies
Journal of Medicinal Chemistry 52 (2009) 2407–2419 doi
Cummings, C.G.; Ross, N.T.; Katt, W.P. & Hamilton, A.D.
Synthesis and Biological Evaluation of a 5-6-5 Imidazole-Phenyl-Thiazole Based α-Helix Mimetic
Organic Letters 11 (2009) 25–28 doi
Deeth, R.J.; Anastasi, A.; Diedrich, C. & Randell, K.
Molecular Modelling for Transition Metal Complexes: Dealing with d-Electron Effects
Coordination Chemistry Reviews 253 (2009) 795–816 doi
Delp, S.A.; Munro-Leighton, C.; Khosla, C.; Templeton, J.L.; Alsop, N.M.; Gunnoe, T.B. & Cundari, T.R.
Combined Experimental and Computational Study of W(II), Ru(II), Pt(IV) and Cu(I) Amine and Amido Complexes Using 15N NMR Spectroscopy
Journal of Organometallic Chemistry 694 (2009) 1549–1556 doi
den Hollander, A.; McGee, T.L.; Ziviello, C.; Banfi, S.; Dryja, T.P.; Gonzalez-Fernandez, F.; Ghosh, D. & Berson, E.
A Homozygous Missense Mutation in the IRBP Gene (RBP3) Associated with Autosomal Recessive Retinitis Pigmentosa
Investigative Ophthalmology & Visual Science 50 (2009) 1864–1872 doi
Deshpande, S.; Solomon, V.R.; Katti, S.B. & Prabhakar, Y.
Topological Descriptors in Modelling Antimalarial Activity: N1-(7-chloro-4-quinolyl)-1,4-bis (3-aminopropyl) Piperazine as Prototype
Journal of Enzyme Inhibition and Medicinal Chemistry 24 (2009) 94–104 doi
Elsässer, B.; Valiev, M. & Weare, J.H.
A Dianionic Phosphorane Intermediate and Transition States in an Associative AN+DN Mechanism for the RibonucleaseA Hydrolysis Reaction
Journal of the American Chemical Society 131 (2009) 3869–3871 doi
Enomoto, H.; Morikawa, Y.; Miyake, Y.; Tsuji, F.; Mizuchi, M.; Suhara, H.; Fujimura, K.; Horiuchi, M. & Ban, M.
Synthesis and Biological Evaluation of N-Mercaptoacylcysteine Derivatives as Leukotriene A4 Hydrolase Inhibitors
Bioorganic & Medicinal Chemistry Letters 19 (2009) 442–446 doi
Ermondi, G.; Cravotto, G. & Balliano, G.
Umbelliferone aminoalkyl derivatives as inhibitors of human oxidosqualene-lanosterol cyclase
Journal of Enzyme Inhibition and Medicinal Chemistry 24 (2009) 589–598 doi
Erős, D.; Őrfi, L.; Csuka, I.; Kéri, G. & Hrabák, A.
Binding Specificity of the L-Arginine Transport Systems in Mouse Macrophages and Human Cells Overexpressing the Cationic Amino Acid Transporter hCAT-1
Amino Acids 36 (2009) 483–492 doi
Fjell, C.D.; Jenssen, H.; Hilpert, K.; Cheung, W.A.; Panté, N.; Hancock, R.E.W. & Cherkasov, A.
Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning
Journal of Medicinal Chemistry 52 (2009) 2006–2015 doi
Francalanci, F.; Avolio, M.; De Luca, E.; Longo, D.; Menchise, V.; Guazzi, P.; Sgrň, F.; Marino, M.; Goitre, L.; Balzac, F.; Trabalzini, L. & Retta, S.F.
Structural and Functional Differences between KRIT1A and KRIT1B Isoforms: A Framework for Understanding CCM Pathogenesis
Experimental Cell Research 315 (2009) 285–303 doi
Ghosh, D.; Griswold, J.; Erman, M. & Pangborn, W.
Structural Basis for Androgen Specificity and Oestrogen Synthesis in Human Aromatase
Nature 457 (2009) 219–223 doi
Gleeson, M.P. & Gleeson, D.
QM/MM Calculations in Drug Discovery: A Useful Method for Studying Binding Phenomena?
Journal of Chemical Information and Modeling 49 (2009) 670–677 doi
Gooptu, B.; Miranda, E.; Nobeli, I.; Mallya, M.; Purkiss, A.; Leigh Brown, S.C.; Summers, C.; Phillips, R.L.; Lomas, D.A. & Barrett, T.E.
Crystallographic and Cellular Characterisation of Two Mechanisms Stabilising the Native Fold of α1-Antitrypsin: Implications for Disease and Drug Design
Journal of Molecular Biology 387 (2009) 857–868 doi
Green, R.C.E.; Thumser, A.E.; Povey, D.; Saldanha, J.W.; Potter, B.S.; Palmer, R.A. & Howlin, B.J.
A Comparative Study of the Single Crystal X-ray Determination and Molecular Modelling of the Binding of Oligomycin to ATP Synthase
Computational Biology and Chemistry (2009) doi
Grycova, L.; Sklenovsky, P.; Lansky, Z.; Janovska, M.; Otyepka, M.; Amler, E.; Teisinger, J. & Kubala, M.
ATP and magnesium drive conformational changes of the Na+/K--ATPase cytoplasmic headpiece
Biochimica et Biophysica Acta - Biomembranes 1788 (2009) 1081–1091 doi
Guo, H.; Gorin, A. & Guo, H.
A peptide-linkage deletion procedure for estimate of energetic contributions of individual peptide groups in a complex environment: Application to parallel β-Sheets
Interdisciplinary Sciences: Computational Life Sciences 1 (2009) 12–20 doi
Hähnke, V.; Hofmann, B.; Grgat, T.; Proschak, E.; Steinhilber, D. & Schneider, G.
PhAST: Pharmacophore Alignment Search Tool
Journal of Computational Chemistry 30 (2009) 761–771 doi
Harada, M.; Murakami, H.; Okawa, A.; Okimoto, N.; Hiraoka, S.; Nakahara, T.; Akasaka, R.; Shiraishi, Y.; Futatsugi, N.; Mizutani-Koseki, Y.; Kuroiwa, A.; Shirouzu, M.; Yokoyama, S.; Taiji, M.; Iseki, S.; Ornitz, D.M. & Koseki, H.
FGF9 Monomer–Dimer Equilibrium Regulates Extracellular Matrix Affinity and Tissue Diffusion
Nature Genetics 41 (2009) 289–298 doi
Hecht, D. & Fogel, G.B.
A Novel In Silico Approach to Drug Discovery via Computational Intelligence
Journal of Chemical Information and Modeling 49 (2009) 1105–1121 doi
Heinke, R.; Spannhoff, A.; Meier, R.; Trojer, P.; Bauer, I.; Jung, M. & Sippl, W.
Virtual Screening and Biological Characterization of Novel Histone Arginine Methyltransferase PRMT1 Inhibitors
ChemMedChem 4 (2009) 69–77 doi
Hödl, C.; Raunegger, K.; Strommer, R.; Ecker, G.F.; Kunert, O.; Sturm, S.; Seger, C.; Haslinger, E.; Steiner, R.; Strauss, W.S.L. & Schramm, H.-W.
Syntheses and Antigestagenic Activity of Mifepristone Derivatives
Journal of Medicinal Chemistry 52 (2009) 1268–1274 doi
Huang, Y.-m. & Bystroff, C.
Complementation and Reconstitution of Fluorescence from Circularly Permuted and Truncated Green Fluorescent Protein
Biochemistry 48 (2009) 929–940 doi
Imai, Y.N.; Ryu, S. & Oiki, S.
Docking Model of Drug Binding to the Human Ether-à-go-go Potassium Channel Guided by Tandem Dimer Mutant Patch-Clamp Data: A Synergic Approach
Journal of Medicinal Chemistry 52 (2009) 1630–1638 doi
Islam, K.M.D.; Dilcher, M.; Thurow, C.; Vock, C.; Krimmelbein, I.K.; Tietze, L.F.; Gonzalez, V.; Zhao, H. & Gatz, C.
Directed Evolution of Estrogen Receptor Proteins with Altered Ligand-binding Specificities
Protein Engineering, Design and Selection 22 (2009) 45–52 doi
Jackson, T.A.; Robertson, V.; Imberty, A. & Auzanneau, F.I.
The flexibility of the LeaLex Tumor Associated Antigen central fragment studied by systematic and stochastic searches as well as dynamic simulations
Bioorganic & Medicinal Chemistry 17 (2009) 1514–1526 doi
Johnson, S.M.; Connelly, S.; Wilson, I.A. & Kelly, J.W.
Toward Optimization of the Second Aryl Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies
Journal of Medicinal Chemistry 52 (2009) 1115–1125 doi
Kato-Takagaki, K.; Mizukoshi, Y.; Yoshizawa, Y.; Akazawa, D.; Torii, Y.; Ono, K.; Tanimura, R.; Shimada, I. & Takahashi, H.
Structural and Interaction Analysis of Glycoprotein VI-binding Peptide Selected from Phage Display Library
Journal of Biological Chemistry 284 (2009) 10720–10727 doi
Kawashima, T.; Bao, Y.C.; Minoshima, Y.; Nomura, Y.; Hatori, T.; Hori, T.; Fukagawa, T.; Fukada, T.; Takahashi, N.; Nosaka, T.; Inoue, M.; Sato, T.; Kukimoto-Niino, M.; Shirouzu, M.; Yokoyama, S. & Kitamura, T.
A Rac GTPase activating protein MgcRacGAP is an NLS-containing nuclear chaperone in the activation of STAT transcription factors
Molecular and Cellular Biology 29 (2009) 1796–1813 doi
Koba, H.; Okuda, K.; Watanabe, H.; Tagami, J. & Senpuku, H.
Role of lysine in interaction between surface protein peptides of Streptococcus gordonii and agglutinin peptide
Oral Microbiology and Immunology 24 (2009) 162–169 doi
Koeberle, A.; Siemoneit, U.; Northoff, H.; Hofmann, B.; Schneider, G. & Werz, O.
MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregation
European Journal of Pharmacology 608 (2009) 804–890 doi
Kortagere, S.; Krasowski, M.D. & Ekins, S.
The importance of discerning shape in molecular pharmacology
Trends in Pharmacological Sciences 30 (2009) 138–147 doi
Krasowski, M.D.; Siam, M.G.; Iyer, M.; Pizon, A.F.; Giannoutsos, S. & Ekins, S.
Chemoinformatic Methods for Predicting Interference in Drug of Abuse/Toxicology Immnoassays
Clinical Chemistry (2009) doi
Kularatne, S.A.; Zhou, Z.; Yang, J.; Post, C.B. & Low, P.S.
Design, Synthesis, and Pre-clinical Evaluation of Prostate-Specific Membrane Antigen (PSMA)-Targeted 99mTc-Radioimaging Agents
Molecular Pharmaceutics (2009) doi
La Motta, C.; Sartini, S.; Mugnaini, L.; Salerno, S.; Simorini, F.; Taliani, S.; Marini, A.M.; Da Settimo, F.; Lavecchia, A.; Novellino, E.; Antonioli, L.; Fornai, M.; Blandizzi, C. & Del Tacca, M.
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one Ring System as a Useful Template To Obtain Potent Adenosine Deaminase Inhibitors
Journal of Medicinal Chemistry 52 (2009) 1681–1692 doi
Lambertucci, C.; Antonini, I.; Buccioni, M.; Ben, D.D.; Kachare, D.D.; Volpini, R.; Klotz, K.-N. & Cristalli, G.
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands
Bioorganic & Medicinal Chemistry 17 (2009) 2812–2822 doi
Lebsack, A.D.; Branstetter, B.J.; Hack, M.D.; Xiao, W.; Peterson, M.L.; Nasser, N.; Maher, M.P.; Ao, H.; Bhattacharya, A.; Kansagara, M.; Scott, B.P.; Luo, L.; Rynberg, R.; Rizzolio, M.; Chaplana, S.R.; Wickenden, A.D. & Breitenbucher, J.G.
Identification and Synthesis of 2,7-diamino-thiazolo [5,4-d] Pyrimidine Derivatives as TRPV1 Antagonists
Bioorganic & Medicinal Chemistry Letters 19 (2009) 40–46 doi
Lehto, P.; Aaltonen, J.; Tenho, M.; Rantanen, J.; Hirvonen, J.; Tanninen, V.P. & Peltonen, L.
Solvent-Mediated Solid Phase Transformations of Carbamazepine: Effects of Simulated Intestinal Fluid and Fasted State Simulated Intestinal Fluid
Journal of Pharmaceutical Sciences 98 (2009) 985–996 doi
Lin, Y.S.; Yasuda, K.; Assem, M.; Cline, C.; Barber, J.; Li, C.-W.; Kholodovych, V.; Ai, N.; Chen, J.D.; Welsh, W.J.; Sean Ekins & Schuetz, E.G.
The Major Human PXR Splice Variant, PXR.2, Exhibits Significantly Diminished Ligand-activated Transcriptional Regulation
Drug Metabolism and Disposition (2009) doi
Lounkine, E. & Bajorath, J.
Topological Fragment Index for the Analysis of Molecular Substructures and Their Topological Environment in Active Compounds
Journal of Chemical Information and Modeling 49 (2009) 162–168 doi
Maeda, M.H. & Kinoshita, K.
Development of New Indices to Evaluate Protein-Protein Interfaces: Assembling Space Volume, Assembling Space Distance, and Global Shape Descriptor
Journal of Molecular Graphics and Modelling 27 (2009) 706–711 doi
Markt, P.; Feldmann, C.; Rollinger, J.M.; Raduner, S.; Schuster, D.; Kirchmair, J.; Distinto, S.; Spitzer, G.M.; Wolber, G.; Laggner, C.; Altmann, K.-H.; Langer, T. & Gertsch, J.
Discovery of Novel CB2 Receptor Ligands by a Pharmacophore-Based Virtual Screening Workflow
Journal of Medicinal Chemistry 52 (2009) 369–378 doi
Marx, I.E.; DiMauro, E.F.; Cheng, A.; Emkey, R.; Hitchcock, S.A.; Huang, L.; Huang, M.Y.; Human, J.; Lee, J.H.; Li, X.; Martin, M.W.; White, R.D.; Fremeau Jr., R.T. & Patel, V.F.
Discovery of α-amidosulfones as Potent and Selective Agonists of CB2: Synthesis, SAR, and Pharmacokinetic Properties
Bioorganic & Medicinal Chemistry Letters 19 (2009) 31–35 doi
Masciocchi, J.; Frau, G.; Fanton, M.; Sturlese, M.; Floris, M.; Pireddu, L.; Palla, P.; Cedrati, F.; Rodriguez-Tomé, P. & Moro, S.
MMsINC: A Large-scale Chemoinformatics Database
Nucleic Acids Research 37 (2009) D284–D290 doi
Matthews, L.; Berry, A.; Tersigni, M.; D'Acquisto, F.; Ianaro, A. & Ray, D.
Thiazolidinediones Are Partial Agonists for the Glucocorticoid Receptor
Endocrinology 150 (2009) 75–86 doi
McGuigan, C.; Bidet, O.; Derudas, M.; Andrei, G.; Snoeck, R. & Balzarini, J.
Alkenyl substituted bicyclic nucleoside analogues retain nanomolar potency against Varicella Zoster Virus
Bioorganic & Medicinal Chemistry 17 (2009) 3025–3027 doi
Medina-Franco, J.L.; Martínez-Mayorga, K.; Bender, A.; Marín, R.M.; Giulianotti, M.A.; Pinilla, C. & Houghten, R.A.
Characterization of Activity Landscapes Using 2D and 3D Similarity Methods: Consensus Activity Cliffs
Journal of Chemical Information and Modeling 49 (2009) 477–491 doi
Miao, L. & Schulten, K.
Transport-Related Structures and Processes of the Nuclear Pore Complex Studied through Molecular Dynamics
Structure 17 (2009) 449–459 doi
Miller, J.R.; Dunham, S.; Mochalkin, I.; Banotai, C.; Bowman, M.; Buist, S.; Dunkle, B.; Hanna, D.; Harwood, H.J.; Huband, M.D.; Karnovsky, A.; Kuhn, M.; Limberakis, C.; Liu, J.Y.; Mehrens, S.; Mueller, W.T.; Narasimhan, L.; Ogden, A.; Ohren, J.; Prasad, J.V.N.V.; Shelly, J.A.; Skerlos, L.; Sulavik, M.; Thomas, V.H.; VanderRoest, S.; Wang, L.; Wang, Z.; Whitton, A.; Zhu, T. & Stover, C.K.
A Class of Selective Antibacterials Derived From a Protein Kinase Inhibitor Pharmacophore
Proceedings of the National Academy of Sciences U.S.A. 106 (2009) 1737–1742 doi
Mitchell, W.L.; Giblin, G.M.P.; Naylor, A.; Eatherton, A.J.; Slingsby, B.P.; Rawlings, A.D.; Jandu, K.S.; Haslam, C.P.; Brown, A.J.; Goldsmith, P.; Clayton, N.M.; Wilson, A.W.; Chessell, I.P.; Green, R.H.; Whittington, A.R. & Wall, I.D.
Pyridine-3-carboxamides as Novel CB2 Agonists for Analgesia
Bioorganic & Medicinal Chemistry Letters 19 (2009) 259–263 doi
Miyamoto, S.; Kawai, A.; Higuchi, S.; Nishi, Y.; Tanimoto, T.; Uekaji, Y.; Nakata, D.; Fukumi, H. & Terao, K.
Structural Studies of Coenzyme Q10 Inclusion Complex with γ-cyclodextrin Using Chemical Analyses and Molecular Modeling
Chem-Bio Informatics Journal 9 (2009) 1–11 doi
Mulakala, C. & Kaznessis, Y.N.
Path-Integral Method for Predicting Relative Binding Affinities of Protein–Ligand Complexes
Journal of the American Chemical Society 131 (2009) 4521–4528 doi
Neres, J.; Brewer, M.L.; Ratier, L.; Botti, H.; Buschiazzo, A.; Edwards, P.N.; Mortenson, P.N.; Charlton, M.H.; Alzari, P.M.; Frasch, A.C.; Bryce, R.A. & Douglas, K.T.
Discovery of Novel Inhibitors of Trypanosoma cruzi trans-sialidase from in silico Screening
Bioorganic & Medicinal Chemistry Letters 19 (2009) 589–596 doi
Niimi, N.; Sassa, A.; Katafuchi, A.; Grúz, P.; Fujimoto, H.; Bonala, R.-R.; Johnson, F.; Ohta, T. & Nohmi, T.
The Steric Gate Amino Acid Tyrosine 112 Is Required for Efficient Mismatched-Primer Extension by Human DNA Polymerase κ
Biochemistry (2009) doi
Okada, Y.; Murayama, N.; Yanagida, C.; Shimizu, M.; Guengerich, F.P. & Yamazaki, H.
Drug Interactions of Thalidomide with Midazolam and Cyclosporine A: Heterotropic Cooperativity of Human Cytochrome P450 3A5
Drug Metabolism and Disposition 37 (2009) 18–23 doi
Okano, M.; Mito, J.; Maruyama, Y.; Masuda, H.; Niwa, T.; Nakagawa, S.; Nakamura, Y. & Matsuura, A.
Discovery and structure-activity relationships of 4-aminoquinazoline derivatives, a novel class of opioid receptor like-1 (ORL1) antagonists
Bioorganic & Medicinal Chemistry 17 (2009) 119–132 doi
Okazaki, S.; Suzuki, A.; Mizushima, T.; Kawano, T.; Komeda, H.; Asano, Y. & Yamane, T.
The Novel Structure of a Pyridoxal 5′-Phosphate-Dependent Fold-Type I Racemase, α-Amino-ε-caprolactam Racemase from Achromobacter obae
Biochemistry 48 (2009) 941–950 doi
Oyarzabal, J.; Howe, T.; Alcazar, J.; Andrés, J.I.; Alvarez, R.M.; Dautzenberg, F.; Iturrino, L.; Martínez, S. & Van der Linden, I.
Novel Approach for Chemotype Hopping Based on Annotated Databases of Chemically Feasible Fragments and a Prospective Case Study: New Melanin Concentrating Hormone Antagonists
Journal of Medicinal Chemistry 52 (2009) 2076–2089 doi
Ozaki, M. & Seto, T.
Noble Gas Anesthetics and Immobilizers Show Different Binding Distributions to KcsA Channel
Biophysical Journal 96 (2009) 40a doi
Pabuwal, V. & Li, Z.
Comparative analysis of the packing topology of structurally important residues in helical membrane and soluble proteins
Protein Engineering, Design and Selection 22 (2009) 67–73 doi
Pautus, S.; Aboraia, A.S.; Bassett, C.E.; Brancale, A.; Coogan, M.P. & Simons, C.
Design and synthesis of substituted imidazole and triazole N-phenylbenzo [d] oxazolamine inhibitors of retinoic acid metabolizing enzyme CYP26
Journal of Enzyme Inhibition and Medicinal Chemistry 24 (2009) 487–498 doi
Peach, M.L.; Tan, N.; Choyke, S.J.; Giubellino, A.; Athauda, G.; Burke, T.R.; Nicklaus, M.C. & Bottaro, D.P.
Directed Discovery of Agents Targeting the Met Tyrosine Kinase Domain by Virtual Screening
Journal of Medicinal Chemistry 52 (2009) 943–951 doi
Pedras, B.; Oliveira, E.; Santos, H.; Rodríguez, L.; Crehuet, R.; Avilés, T.; Capelo, J.L. & Lodeiro, C.
A new tripodal poly-imine indole-containing ligand: Synthesis, complexation, spectroscopic and theoretical studies
Inorganica Chimica Acta 362 (2009) 2627–2635 doi
Pellegrino, S.; Clerici, F.; Contini, A.; Leone, S.; Pilati, T. & Gelmi, M.L.
Chemoselective asymmetric synthesis of C-3a-(3-hydroxypropyl)-tetrahydropyrrolo[2,3-b]indole and C-4a-(2-aminoethyl)-tetrahydropyrano[2,3-b]indole derivatives
Tetrahedron 65 (2009) 1995–2004 doi
Pérez-Nueno, V.I.; Pettersson, S.; Ritchie, D.W.; Borrell, J.I. & Teixidó, J.
Discovery of Novel HIV Entry Inhibitors for the CXCR4 Receptor by Prospective Virtual Screening
Journal of Chemical Information and Modeling 49 (2009) 810–823 doi
Pérez-Nueno, V.I.; Rabal, O.; Borrell, J.I. & Teixidó, J.
APIF: A New Interaction Fingerprint Based on Atom Pairs and Its Application to Virtual Screening
Journal of Chemical Information and Modeling (2009) doi
Pérez-Toledo, K.; Rojas-Meza, A.P.; Mancio-Silva, L.; Hernández-Cuevas, N.A.; Delgadillo, D.M.; Vargas, M.; Martínez-Calvillo, S.; Scherf, A. & Hernandez-Rivas, R.
Plasmodium falciparum heterochromatin protein 1 binds to tri-methylated histone 3 lysine 9 and is linked to mutually exclusive expression of var genes
Nucleic Acids Research (2009) doi
Piscitelli, F.; Coluccia, A.; Brancale, A.; La Regina, G.; Sansone, A.; Giordano, C.; Balzarini, J.; Maga, G.; Zanoli, S.; Samuele, A.; Cirilli, R.; La Torre, F.; Lavecchia, A.; Novellino, E. & Silvestri, R.
Indolylarylsulfones Bearing Natural and Unnatural Amino Acids. Discovery of Potent Inhibitors of HIV-1 Non-Nucleoside Wild Type and Resistant Mutant Strains Reverse Transcriptase and Coxsackie B4 Virus
Journal of Medicinal Chemistry 52 (2009) 1922–1934 doi
Rupp, M.; Schneider, P. & Schneider, G.
Distance Phenomena in High-Dimensional Chemical Descriptor Spaces: Consequences for Similarity-Based Approaches
Journal of Computational Chemistry (2009) doi
Sabbaghian, M.; Ebrahim-Habibi, A. & Nemat-Gorgani, M.
Thermal aggregation of a model allosteric protein in different conformational states
International Journal of Biological Macromolecules 44 (2009) 156–162 doi
Sapino, S.; Carlotti, M.; Caron, G.; Ugazio, E. & Cavalli, R.
In silico design, photostability and biological properties of the complex resveratrol/hydroxypropyl-β-cyclodextrin
Journal of Inclusion Phenomena and Macrocyclic Chemistry 63 (2009) 171–180 doi
Shadnia, H.; Wright, J.S. & Anderson, J.M.
Interaction Force Diagrams: New Insight into Ligand-Receptor Binding
Journal of Computer-Aided Molecular Design 23 (2009) 185–194 doi
Shakesby, A.J.; Wallace, I.S.; Isaacs, H.V.; Pritchard, J.; Roberts, D.M. & Douglas, A.E.
A water-specific aquaporin involved in aphid osmoregulation
Insect Biochemistry and Molecular Biology 1 (2009) 1–10 doi
Singh, N.; Guha, R.; Giulianotti, M.A.; Pinilla, C.; Houghten, R.A. & Medina-Franco, J.L.
Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository
Journal of Chemical Information and Modeling 49 (2009) 1010–1024 doi
Spies, M.A.; Reese, J.G.; Dodd, D.; Pankow, K.L.; Blanke, S.R. & Baudry, J.
Determinants of Catalytic Power and Ligand Binding in Glutamate Racemase
Journal of the American Chemical Society 131 (2009) 5274–5284 doi
Suenaga, A.; Hatakeyama, M.; Kiyatkin, A.; Radhakrishnan, R.; Taiji, M. & Kholodenko, B.
Molecular Dynamics Simulations Reveal that Tyr-317 Phosphorylation Reduces Shc Binding Affinity for Phosphotyrosyl Residues of Epidermal Growth Factor Receptor
Biophysical Journal 96 (2009) 2278–2288 doi
Tagami, A.; Ishibashi, N.; Kato, D.; Taguchi, N.; Mochizuki, Y.; Watanabe, H.; Ito, M. & Tanaka, S.
Ab initio quantum-chemical study on emission spectra of bioluminescent luciferases by fragment molecular orbital method
Chemical Physics Letters 472 (2009) 118–123 doi
Taguchi, N.; Mochizuki, Y.; Nakano, T.; Amari, S.; Fukuzawa, K.; Ishikawa, T.; Sakurai, M. & Tanaka, S.
Fragment Molecular Orbital Calculations on Red Fluorescent Proteins (DsRed and mFruits)
The Journal of Physical Chemistry B 113 (2009) 1153–1161 doi
Thiry, A.; Ledecq, M.; Cecchi, A.; Frederick, R.; Dogné, J.M.; Supuran, C.T.; Wouters, J. & Masereel, B.
Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors
Bioorganic & Medicinal Chemistry 17 (2009) 553–557 doi
Thorsteinson, N.; Ban, F.; Santos-Filho, O.; Tabaei, S.M.H.; Miguel-Queralt, S.; Underhill, C.; Cherkasov, A. & Hammond, G.L.
In Silico Identification of Anthropogenic Chemicals As Ligands of Zebrafish Sex Hormone Binding Globulin
Toxicology and Applied Pharmacology 234 (2009) 47–57 doi
Topiol, S. & Sabio, M.
X-ray structure breakthroughs in the GPCR transmembrane region
Biochemical Pharmacology (2009) doi
Tosco, P.; Ahring, P.K.; Dyhring, T.; Peters, D.; Harpsøe, K.; Liljefors, T. & Balle, T.
Complementary Three-Dimensional Quantitative Structure–Activity Relationship Modeling of Binding Affinity and Functional Potency: A Study on α4β2 Nicotinic Ligands
Journal of Medicinal Chemistry 52 (2009) 2311–2316 doi
Tran, T.D.; Park, H.; Kim, H.P.; Ecker, G.F. & Thai, K.M.
Inhibitory activity of prostaglandin E2 production by the synthetic 2'-hydroxychalcone analogues: Synthesis and SAR study
Bioorganic & Medicinal Chemistry Letters 19 (2009) 1650–1653 doi
Tresadern, G.; Bemporad, D. & Howe, T.
A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor
Journal of Molecular Graphics and Modelling (2009) doi
Ulens, C.; Akdemir, A.; Jongejan, A.; van Elk, R.; Bertrand, S.; Perrakis, A.; Leurs, R.; Smit, A.B.; Sixma, T.K.; Bertrand, D. & de Esch, I.J.P.
Use of Acetylcholine Binding Protein in the Search for Novel α7 Nicotinic Receptor Ligands. In Silico Docking, Pharmacological Screening, and X-ray Analysis
Journal of Medicinal Chemistry 52 (2009) 2372–2383 doi
Vanlaer, S.; Voet, A.; Gielens, C.; De Maeyer, M. & Compernolle, F.
Bridged 5,6,7,8-Tetrahydro-1,6-naphthyridines, Analogues of Huperzine A: Synthesis, Modelling Studies and Evaluation as Inhibitors of Acetylcholinesterase
European Journal of Organic Chemistry 5 (2009) 643–654 doi
Vasanthanathan, P.; Hritz, J.; Taboureau, O.; Olsen, L.; Jørgensen, F.S.; Vermeulen, N.P.E. & Oostenbrink, C.
Virtual Screening and Prediction of Site of Metabolism for Cytochrome P450 1A2 Ligands
Journal of Chemical Information and Modeling 49 (2009) 43–52 doi
Vasanthanathan, P.; Taboureau, O.; Oostenbrink, C.; Vermeulen, N.P.E.; Olsen, L. & Jørgensen, F.S.
Classification of Cytochrome P450 1A2 Inhibitors and Non-Inhibitors by Machine Learning Techniques
Drug Metabolism and Disposition 37 (2009) 658–664 doi
Wassermann, A.M.; Geppert, H. & Bajorath, J.
Searching for Target-Selective Compounds Using Different Combinations of Multiclass Support Vector Machine Ranking Methods, Kernel Functions, and Fingerprint Descriptors
Journal of Chemical Information and Modeling 49 (2009) 582–592 doi
Watanabe, H.; Matsumaru, H.; Ooishi, A.; Feng, Y.; Odahara, T.; Suto, K. & Honda, S.
Optimizing pH-response of affinity between protein G and IgG Fc: How electrostatic modulations affect protein-protein interactions
Journal of Biological Chemistry 284 (2009) 12373–12383 doi
Watanabe, T.; Arisawa, M.; Narusuye, K.; Alam, M.S.; Yamamoto, K.; Mitomi, M.; Ozoe, Y. & Nishida, A.
Alantrypinone and its derivatives: Synthesis and antagonist activity toward insect GABA receptors
Bioorganic & Medicinal Chemistry 17 (2009) 94–110 doi
Wawer, M.; Peltason, L. & Bajorath, J.
Elucidation of Structure—Activity Relationship Pathways in Biological Screening Data
Journal of Medicinal Chemistry 52 (2009) 1075–1080 doi
Weill, N. & Rognan, D.
Development and Validation of a Novel Protein–Ligand Fingerprint To Mine Chemogenomic Space: Application to G Protein-Coupled Receptors and Their Ligands
Journal of Chemical Information and Modeling 49 (2009) 1049–1062 doi
Wichapong, K.; Lindner, M.; Pianwanit, S.; Kokpol, S. & Sippl, W.
Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors
European Journal of Medicinal Chemistry 44 (2009) 1383–1395 doi
Williamson, D.S.; Borgognoni, J.; Clay, A.; Daniels, Z.; Dokurno, P.; Drysdale, M.J.; Foloppe, N.; Francis, G.L.; Graham, C.J.; Howes, R.; Macias, A.T.; Murray, J.B.; Parsons, R.; Shaw, T.; Surgenor, A.E.; Terry, L.; Wang, Y.; Wood, M. & Massey, A.J.
Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design
Journal of Medicinal Chemistry 52 (2009) 1510–1513 doi
Zhang, Y.; Cao, R.; Yin, F.; Hudock, M.P.; Guo, R.-T.; Krysiak, K.; Mukherjee, S.; Gao, Y.-G.; Robinson, H.; Song, Y.; No, J.H.; Bergan, K.; Leon, A.; Cass, L.; Goddard, A.; Chang, T.-K.; Lin, F.-Y.; Van Beek, E.; Papapoulos, S.; Wang, A.H.-J.; Kubo, T.; Ochi, M.; Mukkamala, D. & Oldfield, E.
Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR Investigation
Journal of the American Chemical Society 131 (2009) 5153–5162 doi
Site Map | Careers | Contact Us | Legal Notice
www.chemcomp.com